Publications by authors named "Ke-di Zhang"
Article Synopsis
- Robotic pancreaticoduodenectomy (RPD) is becoming a common treatment for primary nonampullary duodenal adenocarcinoma (PNDA), showing several benefits over traditional open pancreaticoduodenectomy (OPD).
- A comparative study involving 49 RPD and 43 OPD patients revealed that RPD resulted in less blood loss, quicker return to oral intake, and shorter hospital stays, while showing no significant differences in major complications or survival rates.
- Overall, RPD is considered a safe and effective alternative to OPD for treating PNDA, but more extensive randomized trials are needed to further assess its effectiveness.
Background: Nab-paclitaxel plus gemcitabine (AG) has resulted in higher tumor response and survival rates for metastatic or advanced pancreatic ductal adenocarcinoma (PDAC) compared with gemcitabine (GEM) alone.
Aim: To examine the feasibility and safety of AG adjuvant chemotherapy of resectable PDAC.
Methods: We retrospectively analyzed patients with resected PDAC who received AG or GEM as postoperative adjuvant treatment between January 2013 and December 2016 at the Chinese People's Liberation Army General Hospital, Beijing, China.
Retrocolic versus antecolic gastrointestinal reconstruction in robotic pancreaticoduodenectomy.
J Hepatobiliary Pancreat Sci
November 2019
Background: With the advancement of robotic pancreaticoduodenectomy (RPD), several reconstruction methods have been advocated to make RPD more effective and safer. In this study, we investigated the safety and effectiveness of RPD using a left retrocolic (L-port) technique and compared it with those of RPD using an antecolic technique.
Methods: Between October 2015 and August 2016, we retrospectively reviewed consecutive cases of RPD before and after introducing the L-port technique for gastrointestinal reconstruction.
[A single-team experience with robotic pancreatic surgery in 1010 cases].
Nan Fang Yi Ke Da Xue Xue Bao
February 2018
Objective: To assess the safety and advantages of robotic pancreatic surgery (RPS) based on the single-team experience with 1010 cases.
Methods: The clinical data of 1010 cases of RPS performed by a single team from November, 2011 to September, 2017 in our hospital were collected prospectively and analyzed. In most of cases the surgeries were performed using the third-generation da Vinci robotic surgical system.